Real-world use of sotrovimab for pre-emptive treatment in high-risk hospitalized COVID-19 patients: an observational cross-sectional study
Data on use of monoclonal antibodies (mAbs) in hospitalized patients are limited. In this cross-sectional study, we evaluated the use of mAbs for early treatment of unvaccinated hospitalized patients with mild-to-moderate COVID-19. All inpatients at our center were screened on 27 October 2021. Prima...
Saved in:
Main Authors: | Ong, Sean W. X., Ren, Dongdong, Lee, Pei Hua, Sutjipto, Stephanie, Dugan, Christopher, Khoo, Bo Yan, Tay, Jun Xin, Vasoo, Shawn, Young, Barnaby Edward, Lye, David C. |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/165133 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Effect of goal orientations on pre-emptive downplay.
by: Gooi, Ling Hoong.
Published: (2009) -
Real-world effectiveness of sotrovimab and remdesivir for early treatment of high-risk hospitalized COVID-19 patients: a propensity score adjusted retrospective cohort study
by: Koh, Lin Pin, et al.
Published: (2023) -
Towards a crisis pre-emptive image management model
by: Pang, Augustine
Published: (2013) -
Towards a crisis pre-emptive image management model
by: PANG, Augustine
Published: (2012) -
Towards a crisis pre-emptive image management model
by: PANG, A.
Published: (2014)